REVENUES (Tables)

9 Months Ended

Sep. 30, 2019

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

Schedule of Company's disaggregation of revenues

The following table summarizes the Company’s disaggregation of revenues:

	Nine Months Ended September 30,
(U.S. dollars in thousands)		2019		2018
Pfizer	$	4,701	$	4,649
Brazil	$	7,385	$	2,573
Total revenues from selling goods	$	12,086	$	7,222
Revenues from license and R&D services	$	24,848	$	16,665

Schedule of Company's contracts liability

The following table sets forth data regarding the Company’s contracts liability:

	Nine Months Ended September 30,
(U.S. dollars in thousands)	2019		2018
Contracts liability at the beginning of the period	$	42,895	$	25,015
Additions during the period		22,151		34,929
Revenue recognized during the period		(24,848)		(16,665)
Contracts liability at the end of the period	$	40,198	$	43,279

Schedule of Company's unsatisfied performance obligation

The following table represents the Company’s unsatisfied performance obligation:

	September 30,
(U.S. dollars in thousands)	2019		2018
Unsatisfied performance obligation	$	50,584	$	76,969